Document Detail

Agar in control of hyperbilirubinemia of full-term newborn infants with erythrocyte G-6-PD deficiency.
MedLine Citation:
PMID:  367457     Owner:  NLM     Status:  MEDLINE    
40 full-term newborn infants with erythrocyte glucose-6-phosphate dehydrogenase (G-6-PD) deficiency were used for a study concerning the effectiveness of agar per os in preventing severe hyperbilirubinemia. 20 randomly selected neonates were given agar (1 g/kg/day) orally in 4 daily doses from their 1st to their 5th day of life. 20 infants were not treated and served as controls. Three exchange transfusions were performed in the experimental as well as in the control group. According to these results, agar does not seem to be effective in preventing severe hyperbilirubinemia, which frequently occurs in newborn infants with erythrocyte G-6-PD deficiency.
T Meloni; S Costa; R Corti; S Cutillo
Related Documents :
19732577 - Effects of transfusions in extremely low birth weight infants: a retrospective study.
16939737 - The premature infants in need of transfusion (pint) study: a randomized, controlled tri...
4049487 - Exposure of newborn infants to plasticizers. plasma levels of di-(2-ethylhexyl) phthala...
22008957 - Effect of different levels of docosahexaenoic acid supply on fatty acid status and lino...
11210277 - Long-term expressing of breastmilk.
21631747 - Association between pacifier use and breast-feeding, sudden infant death syndrome, infe...
Publication Detail:
Type:  Clinical Trial; Journal Article    
Journal Detail:
Title:  Biology of the neonate     Volume:  34     ISSN:  0006-3126     ISO Abbreviation:  Biol. Neonate     Publication Date:  1978  
Date Detail:
Created Date:  1979-04-25     Completed Date:  1979-04-25     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0247551     Medline TA:  Biol Neonate     Country:  SWITZERLAND    
Other Details:
Languages:  eng     Pagination:  295-8     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Administration, Oral
Agar / administration & dosage,  therapeutic use*
Bilirubin / blood
Clinical Trials as Topic
Drug Evaluation
Glucosephosphate Dehydrogenase Deficiency / blood,  complications*
Infant, Newborn
Jaundice, Neonatal / etiology,  prevention & control*
Reg. No./Substance:
635-65-4/Bilirubin; 9002-18-0/Agar

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Albumin mRNA from rat liver cells. Analysis of immunoadsorption of individual polyribosomes
Next Document:  Aortic collagen biosynthesis during renal hypertension, pregnancy and hypertension during pregnancy ...